Top Markets
Coin of the day
Baudax Bio, Inc. Baudax Bio, Inc.

Baudax Bio, Inc.

BXRXQ
Rank in Stocks #42133
Baudax Bio, Inc., a biotechnology company, develops and commercializes products... Baudax Bio, Inc., a biotechnology company, develops and commercializes products for hospital and other acute care related settings. The company develops T cell receptor, that focus on immune modulating therapies for orphan diseases or complications associated with such diseases, as well as the treatment of autoimmune disorders. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2015 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$4.36K
Change (1 day)
0.00%
Change (1 year)
900.00%
Country
US
Trade Baudax Bio, Inc. (BXRXQ)

Category

Stock price history for Baudax Bio, Inc. (BXRXQ)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.02 on 2024-02-01
Stock price history of Baudax Bio, Inc. from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 292.50%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -8.05%
KR